Intervene With Jakafi® (ruxolitinib) At the First Sign of Steroid-Refractory Acute and Chronic GVHD – A Real-World, Case-Based Discussion

Speaker: Karolina Faysman, AOCNP, DNP-C

RSVP by 8/25 at http://sphase.info/inc10651.

If you have issues registering contact Beth Fantasia at 304-612-7012 or bfantasia@incyte.com